Legal Representation
Attorney
STACEY R HALPERN
USPTO Deadlines
Application History
49 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Mar 20, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Mar 20, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Jul 19, 2005 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Apr 26, 2005 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 6, 2005 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Feb 9, 2005 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Feb 7, 2005 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jan 20, 2005 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jan 16, 2005 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jan 14, 2005 | ALIE | A | ASSIGNED TO LIE | Loading... |
Nov 16, 2004 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Nov 4, 2004 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
Nov 4, 2004 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
Nov 4, 2004 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Oct 15, 2004 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Oct 15, 2004 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
Mar 19, 2004 | CNRT | O | NON-FINAL ACTION MAILED | Loading... |
Mar 19, 2004 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Feb 11, 2004 | I | PAPER RECEIVED | Loading... | |
Feb 11, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 23, 2003 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
Oct 9, 2003 | CFIT | O | CASE FILE IN TICRS | Loading... |
Sep 25, 2003 | I | PAPER RECEIVED | Loading... | |
Dec 16, 2002 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
Nov 26, 2002 | I | PAPER RECEIVED | Loading... | |
Nov 26, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Aug 5, 2002 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
Jul 8, 2002 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
May 20, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Nov 26, 2001 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
Oct 26, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 26, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 19, 2001 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
Mar 29, 2001 | UNPR | I | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | Loading... |
Dec 1, 2000 | CNSL | F | LETTER OF SUSPENSION MAILED | Loading... |
Sep 14, 2000 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 14, 2000 | CNSI | O | INQUIRY AS TO SUSPENSION MAILED | Loading... |
Sep 21, 1999 | CNSL | F | LETTER OF SUSPENSION MAILED | Loading... |
Jul 29, 1999 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
May 5, 1999 | CNSL | F | LETTER OF SUSPENSION MAILED | Loading... |
Apr 9, 1999 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 6, 1998 | CNSI | O | INQUIRY AS TO SUSPENSION MAILED | Loading... |
May 20, 1998 | CNSL | F | LETTER OF SUSPENSION MAILED | Loading... |
Apr 3, 1998 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 10, 1997 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
Aug 11, 1997 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 11, 1997 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
Jan 16, 1997 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 10, 1997 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
drugs for medical purposes, namely, drugs for central nervous system, namely, general anesthetics, hypnotics and sedatives, anti-epileptics, antipyretics and analgesics, nervous system stimulants, analeptics and anti-dizziness agents; drugs for peripheral nervous system, namely, local anesthetics, skeletal muscle relaxants, autonomics, antispasmodics, diaphoretics and anhidrotics; drugs for sensory organs, namely, agents for ophthalmic use and agents for optic and nasal use; drugs used in allergy, namely, anti-histamines and agents for stimulation therapy; drugs affecting circulatory organs, namely, cardiotonics, agents for arrhythmia, diuretics, hypo tensors, vasosupporters, vasoconstrictors and cerebral hemorrhage prophylactic; agents affecting respiratory organs, namely, respiratory stimulants, antitussives and expectorants and cough wheat gluten; agents for digestive organs, namely, organs for dental use, agents for oral use, stomachics and digestives, antacids, anti-emetics, emetics, choleretics, antidiarrheals, purgatives, clysters, stomach and bowels wash powder, tooth prophylactic, stomatic refrigerant, and stomatic cleanser; hormone preparations, namely, pituitary hormone preparations, salivary gland hormone preparations, thyroid and accessory thyroid hormone preparations, pancreas hormone preparations, adrenal hormone preparations, androgens, estrogens and mixed hormone preparations; agents for urinary, genital and anal organs, namely, urinary antiseptics, oxytocics, agents affecting menstruation, contraceptives and anti-hemorrhoidics; agents affecting epidermis, namely, disinfectants, dermatics for purulence, analgesics, anti-itchings, astringents, cataplasms, anti-dermoinfectives, corrosives, hair remedies, bath preparations, medicated baby powder, medicated baby oil, medicated soap of the Japanese pharmacopoeia; vitamin preparations, namely, vitamin A preparations, vitamin B preparations, vitamin C preparations, vitamin D preparations, composite vitamin preparations compounded of water soluble and fat soluble vitamins, mixed vitamin preparations compounded of water soluble and fat soluble vitamins and cod-liver oil drops; amino acids and preparations, namely, lysine, methionin, tryptophane and threonine; preparations, nutrients, tonics and alternatives, namely, calcium, mineral, saccharide, organic acid, proteins, amino acids, organotherapeutics, chondroitin, foodstuff solidifying agent, medicated wine and royal jelly; agents relating to blood, namely, blood substitutes, hemostatics, anticoagulants and blood-plasma; agents affecting metabolism, namely, lipotropic factor preparations, antidotes, agents for treatment of habitual intoxication, lactogoques and enzyme preparations; agents for activating cellular function, namely, chlorophyll preparations and dyes; anti-cancer and anti-sarcoma tumor suppressing agents; agents used in lesion due to physical stimuli, namely, agents used in thermoplegia and agents used in radiation sickness; agents used in lesion due to chemical stimuli, namely, anti-benzolismus, anti-arsenium and anti-chlorine poisoning; antibiotics and preparations, namely, penicillin, streptomycin, chloramphenicol, erythromycin, thiolutin, tetracycline, colistin-polymyxin, mixed antibiotic, salkomycin and trichomycin; chemotherapeutics agents and preparations, namely, sulfonamide, antituberculotic, antisyphilitics and antiliprotic; biological products, namely, vaccines, toxins, toxoids, antitoxins, antibacterial sera, diagnostic acids for biological tests and mixed biological preparations; agents against parasites, namely, antiprozoals and anthelmintics; agents for dispensing use, namely, excipients, ointment bases, solvents, flavoring agents, room deodorizer and medical coloring agents; labeled isotope substance for treatment and diagnosis; narcotics, namely, opium alkaloids, derivatives and preparations, coca alkaloids, derivatives and preparations and synthetic narcotics; veterinary drugs, namely, vaccines, pain relief medication and preparations for treatment of intestinal bacteria; agents for agriculture or public health, namely, disinfectants, insecticides, fumigants, rodenticides, herbicides, germination controllers, hormones for plants, plant rearing agents, soil improving agents, moth repellents, room deodorants and antiseptics; dental restoration compounds, namely, dental cements, dental prosthetic and filling materials; oblates, namely, thin wafers made from wheat meal or capsules for the purpose of wrapping the aforementioned drugs for medical purposes; gauze; capsules for containing aforementioned drugs for medical purposes; ear bandages; menstruation tampons; sanitary napkins; panties incorporating sanitary pads; absorbent cotton for medical purposes; adhesive medical plasters; bandages for dressings; liquid wound dressings; adult diapers; semen for artificial insemination; powdered milk for babies; menstruation bandages
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005